261 related articles for article (PubMed ID: 7988559)
1. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
Laux G; Adam B; Strobl LJ; Moreau-Gachelin F
EMBO J; 1994 Dec; 13(23):5624-32. PubMed ID: 7988559
[TBL] [Abstract][Full Text] [Related]
2. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
[TBL] [Abstract][Full Text] [Related]
4. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
Zhao B; Sample CE
J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
Zimber-Strobl U; Strobl LJ; Meitinger C; Hinrichs R; Sakai T; Furukawa T; Honjo T; Bornkamm GW
EMBO J; 1994 Oct; 13(20):4973-82. PubMed ID: 7957063
[TBL] [Abstract][Full Text] [Related]
6. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
7. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
Zimber-Strobl U; Kremmer E; Grässer F; Marschall G; Laux G; Bornkamm GW
EMBO J; 1993 Jan; 12(1):167-75. PubMed ID: 8381349
[TBL] [Abstract][Full Text] [Related]
8. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
Strobl LJ; Höfelmayr H; Stein C; Marschall G; Brielmeier M; Laux G; Bornkamm GW; Zimber-Strobl U
Immunobiology; 1997 Dec; 198(1-3):299-306. PubMed ID: 9442401
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
Johannsen E; Koh E; Mosialos G; Tong X; Kieff E; Grossman SR
J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
[TBL] [Abstract][Full Text] [Related]
10. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.
Waltzer L; Logeat F; Brou C; Israel A; Sergeant A; Manet E
EMBO J; 1994 Dec; 13(23):5633-8. PubMed ID: 7988560
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
Waltzer L; Perricaudet M; Sergeant A; Manet E
J Virol; 1996 Sep; 70(9):5909-15. PubMed ID: 8709211
[TBL] [Abstract][Full Text] [Related]
12. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
Henkel T; Ling PD; Hayward SD; Peterson MG
Science; 1994 Jul; 265(5168):92-5. PubMed ID: 8016657
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
[TBL] [Abstract][Full Text] [Related]
14. RBP-J kappa repression activity is mediated by a co-repressor and antagonized by the Epstein-Barr virus transcription factor EBNA2.
Waltzer L; Bourillot PY; Sergeant A; Manet E
Nucleic Acids Res; 1995 Dec; 23(24):4939-45. PubMed ID: 8559649
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1.
Wu DY; Kalpana GV; Goff SP; Schubach WH
J Virol; 1996 Sep; 70(9):6020-8. PubMed ID: 8709224
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion.
Kempkes B; Pawlita M; Zimber-Strobl U; Eissner G; Laux G; Bornkamm GW
Virology; 1995 Dec; 214(2):675-9. PubMed ID: 8553575
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.
Fuentes-Pananá EM; Peng R; Brewer G; Tan J; Ling PD
J Virol; 2000 Sep; 74(17):8166-75. PubMed ID: 10933728
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]